Drugs Today (Barc) · 2012
The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair
A pharmacology review of Cerebrolysin reported neurotrophic mechanisms of brain protection and repair.
View on PubMed (PMID 22514792)◂ RESEARCH LIBRARY
Research Overview
Cerebrolysin
Neurotrophic Peptide Research
CoA on requestPurity CoAResearch use only
In 60 seconds
Cerebrolysin is a preparation of low-molecular-weight neuropeptides and amino acids derived from porcine brain.
- A pharmacology review of Cerebrolysin reported neurotrophic mechanisms of brain protection and repair.
- A review of the clinical use of Cerebrolysin in dementia.
- A Cochrane systematic review assessing the evidence for Cerebrolysin in vascular dementia.
OVERVIEW
Cerebrolysin (Neurotrophic Peptide Research) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Standardised neuropeptide preparation, 60 mg lyophilised powder per vial.. Each published certificate is an independent Janoshik Analytical report naming the compound and its HPLC purity; certificates not yet published can be requested. The summary below outlines documented mechanisms and study areas reported in the research literature.
Scientific name
Neuropeptide preparation (Cerebrolysin)
Molecular weight
Peptide mixture (<10,000 Da fraction)
Vial size
60mg
DOCUMENTED RESEARCH AREAS
- ▸Mimics the action of endogenous neurotrophic factors (BDNF, GDNF, NGF, CNTF) in preclinical models
- ▸Supports neuronal survival and reduces apoptosis under ischaemic and hypoxic conditions
- ▸Promotes synaptogenesis and neuroplasticity in cognitive-performance research
- ▸Modulates amyloid precursor protein processing in neurodegeneration models
- ▸Reduces neuroinflammation and oxidative stress in injured neural tissue
- ▸Studied across stroke, traumatic brain injury, and dementia research paradigms
- ▸Multi-target pleiotropic action distinct from single-receptor neuropeptides
MECHANISM OF ACTION
Cerebrolysin is a preparation of low-molecular-weight neuropeptides and amino acids derived from porcine brain. Research describes neurotrophic-like activity — supporting neuronal survival, plasticity and repair signalling — and it has been studied clinically in dementia and stroke.
- ▸Contains neuropeptide fragments with reported neurotrophic-like activity
- ▸Studied for effects on neuronal survival and synaptic plasticity
- ▸Evaluated in dementia and post-stroke clinical trials
STUDY SUMMARIES
4 peer-reviewed referencesDrugs Aging · 2009
Cerebrolysin: a review of its use in dementia
A review of the clinical use of Cerebrolysin in dementia.
View on PubMed (PMID 19848437)Cochrane Database Syst Rev · 2019
Cerebrolysin for vascular dementia
A Cochrane systematic review assessing the evidence for Cerebrolysin in vascular dementia.
View on PubMed (PMID 31710397)J Neural Transm Suppl · 2002
Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease
A trial reporting sustained cognitive and global-function outcomes with Cerebrolysin in moderately severe Alzheimer’s disease.
View on PubMed (PMID 12456069)CITATIONS
- 1.The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair. Drugs Today (Barc). 2012. PMID 22514792. pubmed.ncbi.nlm.nih.gov/22514792
- 2.Cerebrolysin: a review of its use in dementia. Drugs Aging. 2009. PMID 19848437. pubmed.ncbi.nlm.nih.gov/19848437
- 3.Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2019. PMID 31710397. pubmed.ncbi.nlm.nih.gov/31710397
- 4.Sustained improvement of cognition and global function in patients with moderately severe Alzheimer’s disease. J Neural Transm Suppl. 2002. PMID 12456069. pubmed.ncbi.nlm.nih.gov/12456069
Citations describe findings reported in the referenced preclinical, in-vitro or clinical literature. They are provided for research and educational purposes only and are not a therapeutic claim.
Related compounds: Nootropic & neuropeptide research compounds in the compound encyclopedia.
All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human consumption.
Related Research & Reading
Keep exploring — goal collections, plain-language guides and the wellness journal, all in one place.
RESEARCH BY GOAL
GUIDES & TOOLS
How-To Research Guides
Step-by-step guides — reconstitution, dosing, storage, handling and CoAs.
Explore →Reconstitution Calculator
Work out exact bacteriostatic-water volumes for any vial — a free lab tool.
Explore →Compound Research Library
Per-compound overviews: documented mechanisms, study areas and cited literature.
Explore →Purity CoAs
Independent Janoshik Analytical certificates — compound identity and HPLC purity — published as styled summaries, the rest on request.
Explore →Research Peptide FAQ
Purity, CoAs, storage, shipping and ordering — answered.
Explore →PEPTIDE GLOSSARY
Certificate of Analysis (CoA)
Third-party lab documentation confirming a batch’s identity and purity.
Explore →HPLC Verification
High-performance liquid chromatography — the assay behind the purity figure on every published certificate.
Explore →Reconstitution
Dissolving a lyophilised peptide in bacteriostatic water to a target concentration.
Explore →Lyophilised
Freeze-dried to a stable powder for cold, dark, long-term storage.
Explore →Bacteriostatic Water
Sterile water with 0.9% benzyl alcohol, used to reconstitute peptides.
Explore →Research Use Only
Supplied strictly for laboratory research — not for human consumption.
Explore →FROM THE WELLNESS JOURNAL
Selank Research Brief: A Tuftsin Analogue in Rodent Anxiety Models
2 min read · Peptides, Stress
Explore →Retatrutide Research Brief: What the Phase 2 and Phase 3 Trials Measured
7 min read · Peptides, Metabolic
Explore →TB-500 Research Brief: Thymosin Beta-4 in Cell-Migration and Wound Models
2 min read · Peptides, Recovery
Explore →